Additive effect of AAV-mediated angiopoietin-1 and VEGF expression on the therapy of infarcted heart

This publication has 28 references indexed in Scilit:

• New technique for measurement of left ventricular pressure in conscious mice
  American Journal of Physiology-Heart and Circulatory Physiology, 2004
• Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium
  Biochemical and Biophysical Research Communications, 2003
• Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors
  The Journal of Thoracic and Cardiovascular Surgery, 2003
• Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors
  International Journal of Cardiology, 2003
• Pre‐administration of angiopoietin‐1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model
  The Journal of Gene Medicine, 2003
• Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia
  Life Sciences, 2003
• Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors
  Molecular Therapy, 2003
• Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy
  The EMBO Journal, 2002
• Coadministration of Angiopoietin-1 and Vascular Endothelial Growth Factor Enhances Collateral Vascularization
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
  Proceedings of the National Academy of Sciences, 1996